SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 47 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,979,000 | -0.1% | 2,004,000 | +0.2% | 0.04% | -5.1% |
| Q2 2021 | $1,980,000 | +2.3% | 2,000,000 | 0.0% | 0.04% | -7.1% |
| Q1 2021 | $1,936,000 | -92.1% | 2,000,000 | -92.2% | 0.04% | -91.9% |
| Q4 2020 | $24,403,000 | -38.0% | 25,556,000 | -40.1% | 0.52% | -40.1% |
| Q3 2020 | $39,347,000 | -10.6% | 42,650,000 | -13.8% | 0.87% | -15.8% |
| Q2 2020 | $43,994,000 | +3.1% | 49,490,000 | -6.1% | 1.03% | +11.1% |
| Q1 2020 | $42,668,000 | -5.9% | 52,691,000 | +5.5% | 0.93% | +5.6% |
| Q4 2019 | $45,350,000 | -19.6% | 49,922,000 | -17.7% | 0.88% | -16.8% |
| Q3 2019 | $56,413,000 | -6.4% | 60,655,000 | -1.7% | 1.06% | -9.3% |
| Q2 2019 | $60,252,000 | +21.9% | 61,727,000 | +20.5% | 1.17% | +7.0% |
| Q1 2019 | $49,416,000 | – | 51,234,000 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
| Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
| DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
| AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |